Return on Assets: An indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Calculated as: Income from Continuing Operations / Total Assets
ARYx Therapeutics Inc. (ARYX) had Return on Assets of -267.35% for the most recently reported fiscal year, ending 2009-12-31.
| Income Statement Financials | |
-- |
|
$-33.17M |
|
-- |
|
-- |
|
$31.24M |
|
$-31.24M |
|
$-1.93M |
|
$-33.17M |
|
$-33.17M |
|
$-33.17M |
|
$-33.17M |
|
$-33.17M |
|
$-33.17M |
|
$-31.24M |
|
$-29.97M |
|
27.44M |
|
27.44M |
|
$-1.21 |
|
$-1.21 |
|
| Balance Sheet Financials | |
$8.81M |
|
$2.26M |
|
$3.60M |
|
$12.41M |
|
$8.68M |
|
$5.28M |
|
$6.64M |
|
$15.32M |
|
$-2.92M |
|
$-2.92M |
|
$-2.92M |
|
28.03M |
|
| Cash Flow Statement Financials | |
$-34.97M |
|
$8.41M |
|
$-2.04M |
|
$36.00M |
|
$7.41M |
|
$-28.59M |
|
$2.15M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.01 |
|
-- |
|
-- |
|
2.23 |
|
-3.59 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-35.11M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
1137.41% |
|
1137.41% |
|
|
Return on Assets |
-267.35% |
-1401.22% |
|
$-0.10 |
|
$-1.28 |
|
$-1.27 |
|